Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Ocumetics TechnologyOTCFF 28 Equity-to-Asset is -4.41 as of Mar. 2026. GuruFocus rates OTCFF with a GF Score™ of 28/100. The stock has 2 warning signs investors should review. Among 851 Medical Devices & Instruments companies, Ocumetics Technology ranks worse than 98.12% on this metric.
The historical rank and industry rank for Ocumetics Technology's Equity-to-Asset or its related term are showing as below:
OTCFF'
s Equity-to-Asset Range Over the Past 10 Years
Min: -4.41 Med: -0.25 Max: 0.71
Current: -4.41
During the past 6 years, the highest Equity to Asset Ratio of Ocumetics Technology was 0.71. The lowest was -4.41. And the median was -0.25.
OTCFF's Equity-to-Asset is ranked worse than 98.12% of 851
companies
in the Medical Devices & Instruments industry
Industry Median: 0.64
vs OTCFF: -4.41
Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.
For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.
Ocumetics Technology Equity-to-Asset Related Terms
Ocumetics Technology Equity-to-Asset Historical Data
* Premium members only.
The historical data trend for Ocumetics Technology's Equity-to-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
OTCFF vs ISRG, BDX, MDLN: Equity-to-Asset Comparison
For the Medical Instruments & Supplies subindustry, Ocumetics Technology's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ocumetics Technology Equity-to-Asset vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Ocumetics Technology's Equity-to-Asset distribution charts can be found below:
* The bar in red indicates where Ocumetics Technology's Equity-to-Asset falls into.
Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.
Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.
Ocumetics Technology's Equity to Asset Ratio for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ocumetics Technology (OTCFF) has a Equity-to-Asset of -4.41 as of Mar. 2026. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Ocumetics Technology and its competitors. According to the industry distribution chart, Ocumetics Technology ranks #835 out of 851 companies in the Medical Devices & Instruments industry, placing it in the top 98.1%.
Is Ocumetics Technology's Equity-to-Asset too high?
Ocumetics Technology's current Equity-to-Asset is -4.41. Based on the distribution chart, Ocumetics Technology ranks #835 out of 851 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Ocumetics Technology has a GF Score™ of 28/100, reflecting its overall financial health beyond just this single metric.
How does Ocumetics Technology's Equity-to-Asset compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Ocumetics Technology ranks #835 out of 851 companies for Equity-to-Asset. This places Ocumetics Technology in the lower half of its industry. The industry median Equity-to-Asset is 0.64. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Equity-to-Asset for a Medical Devices & Instruments company?
The median Equity-to-Asset among Medical Devices & Instruments companies is 0.64, based on 851 companies in the industry. Companies in the top quartile (top 25%) have a Equity-to-Asset significantly above this median, while those in the bottom quartile fall well below. However, Equity-to-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Equity-to-Asset mean?
A high Equity-to-Asset can signal that a stock is expensive relative to its fundamentals. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Ocumetics Technology and its competitors. For the Medical Devices & Instruments industry, the median Equity-to-Asset is 0.64 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ocumetics Technology's current Equity-to-Asset is -4.41. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ocumetics Technology stock overvalued right now?
Ocumetics Technology (OTCFF) has a current Equity-to-Asset of -4.41. The current Equity-to-Asset is -4.41. Ocumetics Technology's overall GF Score™ is 28/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Equity-to-Asset calculated?
Equity-to-Asset is calculated from a company's financial statements. For Ocumetics Technology (OTCFF), the current Equity-to-Asset is -4.41 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Ocumetics Technology Corp is a Canadian research and product development company that specializes in adaptive lens designs. The company is engaged in developing an accommodating intraocular lens to eliminate the need for corrective lenses. The company is in the process of developing new lens technology, which is expected to link nerve impulses with the natural mechanisms for accommodation within the human eye.
28GF Score
Get the complete analysis for OTCFF
Equity-to-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OTCFF has been successfully added to your 
